Stock Performance: CIFI HOLD GP (00884.HK) experienced a decline of 3.03%, with short selling amounting to $366.59K and a ratio of 8.460%.

December Sales Figures: The company reported contracted sales of approximately RMB1 billion for December 2025, a decrease of 58.3% year-over-year, with a contracted average selling price of RMB10,400 per sq.m.

Annual Sales Overview: For the entire year of 2025, CIFI HOLD GP's aggregated contracted sales totaled RMB16.1 billion, down 52.2% year-over-year, with an average selling price of RMB10,900 per sq.m.

Equity Owner Sales: Contracted sales attributable to equity owners for December were around RMB500 million, while for the whole year, it was approximately RMB8.29 billion.

Market Performance: The HSI closed at 25,774, down 27 points (0.11%), with muted trading ahead of a long holiday and a total turnover of HK$157.131 billion.

Tech Stocks Movement: KUAISHOU-W fell 3.5% due to a cyberattack, while other tech stocks like TENCENT and XIAOMI also experienced declines, with TENCENT down 2% and XIAOMI down 1.5%.

Real Estate Sector Struggles: CHINA VANKE dropped 2.3% after a bond proposal failed, impacting other real estate stocks like CIFI HOLD GP and KAISA GROUP, which also saw significant declines.

Pharmaceuticals Highlight: CSPC PHARMA surged 7.6% after its chairman increased his shareholding, making it the best-performing blue chip, while other pharmaceutical stocks faced minor losses.

Market Performance: The HSI rose by 47 points (0.18%) to 25,848, while the HSCEI increased by 9 points (0.11%) to 8,949; however, the HSTECH fell by 22 points (0.42%) to 5,503, with a half-day turnover of HKD87.289 billion.

Tech Stocks Overview: KUAISHOU-W was the worst performer, dropping 3.6%, while XIAOMI-W and TENCENT also saw declines. In contrast, BABA-W, MEITUAN-W, BIDU-SW, and JD-SW experienced slight gains.

Real Estate Sector Struggles: CHINA VANKE fell nearly 2% after its bond extension proposal was rejected, with other real estate stocks like CIFI HOLD GP and KAISA GROUP also declining.

Top Performer: CSPC PHARMA surged 6.4%, becoming the best performer among blue chips, following its chairman's significant investment to increase his holdings.

Stock Performance Overview: Various Hong Kong stocks showed mixed performance, with Agile Group and C&D International Group experiencing slight gains, while CIFI Hold GP and China Jinmao saw declines.

Investment Ratings: Investment ratings varied across companies, with several stocks like C&D International Group and China Overseas rated as "Buy," while others like CIFI Hold GP and Country Garden were rated as "Sell (High Risk)."

Short Selling Activity: Significant short selling activity was noted, particularly in stocks like KE Holdings and C&D International Group, indicating investor caution or bearish sentiment.

Market Insights: JPMorgan highlighted that mortgage subsidies alone may not be enough to revitalize the Chinese property market, suggesting a need for broader measures to attract investor confidence.

CIFI HOLD GP Performance: CIFI HOLD GP (00884.HK) reported a slight decline in stock price, down 0.521%, with short selling activity recorded at $26.74K and a ratio of 1.160%.

Project Deliveries: The company disclosed the delivery of over 20,000 units across 49 projects in 32 cities in Mainland China as of November 2025, with notable completions in Nanchang and Nanjing this month.